MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.transproceed.2021.10.004

Медицинская библиотека · Transplantation proceedings · 2021

Allogeneic Kidney Transplantation After COVID-19: A Case Report.

Kijima Yu, Shimizu Tomokazu, Sekido Eri, Kato Shinya, Kano Kana, Toguchi Makoto, Horiuchi Toshihide, Nozaki Taiji, Omoto Kazuya, Inui Masashi, Toma Hiroshi, Iida Shoichi, Takagi Toshio

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND

Patients undergoing organ transplantation are immunosuppressed and already at risk of various diseases. We report about a patient who underwent ABO-incompatible kidney transplantation after coronavirus disease 2019 (COVID-19) without a recurrence of infection.

CASE REPORT: A 68-year-old woman presented with end-stage renal failure owing to primary autosomal dominant polycystic kidney disease; accordingly, hemodialysis was initiated in September 2020. Her medical history included bilateral osteoarthritis, lumbar spinal stenosis, hypertension, and hyperuricemia. In mid-January 2021, she contracted severe acute respiratory syndrome coronavirus 2 infection from her husband. Both of them were hospitalized and received conservative treatment. Because their symptoms were mild, they were discharged after 10 days. The patient subsequently underwent ABO-incompatible kidney transplantation from her husband who recovered from COVID-19 in March 2021. Before kidney transplantation, her COVID-19 polymerase chain reaction test was negative, confirming the absence of pre-existing COVID-19 immediately before the procedure. Computed tomography revealed no pneumonia. Initial immunosuppression was induced by administering tacrolimus, mycophenolate mofetil, methylprednisolone, basiliximab, rituximab, and 30 g of intravenous immunoglobulin. Double-filtration plasmapheresis and plasma exchange were performed once before ABO-incompatible kidney transplantation. The renal allograft functioned immediately, and the postoperative course was normal without rejection. COVID-19 did not recur. In addition, her serum creatinine levels and renal function had otherwise remained stable.

CONCLUSION

Living kidney transplantation was safely performed in a patient with COVID-19 without postoperative complications or rejection. During the COVID-19 pandemic, the possibility of severe acute respiratory syndrome coronavirus 2 infection during transplantation surgery must be considered.

Для цитирования: Kijima Yu, Shimizu Tomokazu, Sekido Eri, Kato Shinya, Kano Kana, Toguchi Makoto, Horiuchi Toshihide, Nozaki Taiji, Omoto Kazuya, Inui Masashi, Toma Hiroshi, Iida Shoichi, Takagi Toshio. Allogeneic Kidney Transplantation After COVID-19: A Case Report.. Transplantation proceedings. 2021. DOI: 10.1016/j.transproceed.2021.10.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.